310 related articles for article (PubMed ID: 35705804)
1. Signatures of copy number alterations in human cancer.
Steele CD; Abbasi A; Islam SMA; Bowes AL; Khandekar A; Haase K; Hames-Fathi S; Ajayi D; Verfaillie A; Dhami P; McLatchie A; Lechner M; Light N; Shlien A; Malkin D; Feber A; Proszek P; Lesluyes T; Mertens F; Flanagan AM; Tarabichi M; Van Loo P; Alexandrov LB; Pillay N
Nature; 2022 Jun; 606(7916):984-991. PubMed ID: 35705804
[TBL] [Abstract][Full Text] [Related]
2. An overview of mutational and copy number signatures in human cancer.
Steele CD; Pillay N; Alexandrov LB
J Pathol; 2022 Jul; 257(4):454-465. PubMed ID: 35420163
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing.
Cortés-Ciriano I; Lee JJ; Xi R; Jain D; Jung YL; Yang L; Gordenin D; Klimczak LJ; Zhang CZ; Pellman DS; ; Park PJ;
Nat Genet; 2020 Mar; 52(3):331-341. PubMed ID: 32025003
[TBL] [Abstract][Full Text] [Related]
4. Whole-exome sequencing identified mutational profiles of squamous cell carcinomas of anus.
Shin S; Park HC; Kim MS; Han MR; Lee SH; Jung SH; Lee SH; Chung YJ
Hum Pathol; 2018 Oct; 80():1-10. PubMed ID: 29555573
[TBL] [Abstract][Full Text] [Related]
5. Whole-exome sequencing and RNA sequencing analyses of acinic cell carcinomas of the breast.
Beca F; Lee SSK; Pareja F; Da Cruz Paula A; Selenica P; Ferrando L; Gularte-Mérida R; Wen HY; Zhang H; Guerini-Rocco E; Rakha EA; Weigelt B; Reis-Filho JS
Histopathology; 2019 Dec; 75(6):931-937. PubMed ID: 31361912
[TBL] [Abstract][Full Text] [Related]
6. The repertoire of copy number alteration signatures in human cancer.
Tao Z; Wang S; Wu C; Wu T; Zhao X; Ning W; Wang G; Wang J; Chen J; Diao K; Chen F; Liu XS
Brief Bioinform; 2023 Mar; 24(2):. PubMed ID: 36806386
[TBL] [Abstract][Full Text] [Related]
7. Evolution of late-stage metastatic melanoma is dominated by aneuploidy and whole genome doubling.
Vergara IA; Mintoff CP; Sandhu S; McIntosh L; Young RJ; Wong SQ; Colebatch A; Cameron DL; Kwon JL; Wolfe R; Peng A; Ellul J; Dou X; Fedele C; Boyle S; Arnau GM; Raleigh J; Hatzimihalis A; Szeto P; Mooi J; Widmer DS; Cheng PF; Amann V; Dummer R; Hayward N; Wilmott J; Scolyer RA; Cho RJ; Bowtell D; Thorne H; Alsop K; Cordner S; Woodford N; Leditschke J; O'Brien P; Dawson SJ; McArthur GA; Mann GJ; Levesque MP; Papenfuss AT; Shackleton M
Nat Commun; 2021 Mar; 12(1):1434. PubMed ID: 33664264
[TBL] [Abstract][Full Text] [Related]
8. Copy number signature analysis tool and its application in prostate cancer reveals distinct mutational processes and clinical outcomes.
Wang S; Li H; Song M; Tao Z; Wu T; He Z; Zhao X; Wu K; Liu XS
PLoS Genet; 2021 May; 17(5):e1009557. PubMed ID: 33945534
[TBL] [Abstract][Full Text] [Related]
9. MEDICC2: whole-genome doubling aware copy-number phylogenies for cancer evolution.
Kaufmann TL; Petkovic M; Watkins TBK; Colliver EC; Laskina S; Thapa N; Minussi DC; Navin N; Swanton C; Van Loo P; Haase K; Tarabichi M; Schwarz RF
Genome Biol; 2022 Nov; 23(1):241. PubMed ID: 36376909
[TBL] [Abstract][Full Text] [Related]
10. CloneCNA: detecting subclonal somatic copy number alterations in heterogeneous tumor samples from whole-exome sequencing data.
Yu Z; Li A; Wang M
BMC Bioinformatics; 2016 Aug; 17():310. PubMed ID: 27538789
[TBL] [Abstract][Full Text] [Related]
11. Genomic profiling in ovarian cancer retreated with platinum based chemotherapy presented homologous recombination deficiency and copy number imbalances of CCNE1 and RB1 genes.
da Costa AABA; do Canto LM; Larsen SJ; Ribeiro ARG; Stecca CE; Petersen AH; Aagaard MM; de Brot L; Baumbach J; Baiocchi G; Achatz MI; Rogatto SR
BMC Cancer; 2019 May; 19(1):422. PubMed ID: 31060523
[TBL] [Abstract][Full Text] [Related]
12. Genomic signatures of past and present chromosomal instability in Barrett's esophagus and early esophageal adenocarcinoma.
Bao C; Tourdot RW; Brunette GJ; Stewart C; Sun L; Baba H; Watanabe M; Agoston AT; Jajoo K; Davison JM; Nason KS; Getz G; Wang KK; Imamura Y; Odze R; Bass AJ; Stachler MD; Zhang CZ
Nat Commun; 2023 Oct; 14(1):6203. PubMed ID: 37794034
[TBL] [Abstract][Full Text] [Related]
13. Forward and reverse mutations in stages of cancer development.
Hu T; Kumar Y; Shazia I; Duan SJ; Li Y; Chen L; Chen JF; Yin R; Kwong A; Leung GK; Mat WK; Wu Z; Long X; Chan CH; Chen S; Lee P; Ng SK; Ho TYC; Yang J; Ding X; Tsang SY; Zhou X; Zhang DH; ; Zhou EX; Xu L; Poon WS; Wang HY; Xue H
Hum Genomics; 2018 Aug; 12(1):40. PubMed ID: 30134973
[TBL] [Abstract][Full Text] [Related]
14. Genomewide copy number analysis of Müllerian adenosarcoma identified chromosomal instability in the aggressive subgroup.
Lee JC; Lu TP; Changou CA; Liang CW; Huang HN; Lauria A; Huang HY; Lin CY; Chiang YC; Davidson B; Lin MC; Kuo KT
Mod Pathol; 2016 Sep; 29(9):1070-82. PubMed ID: 27255164
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of copy number alterations and tumor mutational burden in carcinoma of unknown primary.
Bochtler T; Wohlfromm T; Hielscher T; Stichel D; Pouyiourou M; Kraft B; Neumann O; Endris V; von Deimling A; Stenzinger A; Krämer A
Genes Chromosomes Cancer; 2022 Sep; 61(9):551-560. PubMed ID: 35430765
[TBL] [Abstract][Full Text] [Related]
16. APOBEC mutagenesis, kataegis, chromothripsis in EGFR-mutant osimertinib-resistant lung adenocarcinomas.
Selenica P; Marra A; Choudhury NJ; Gazzo A; Falcon CJ; Patel J; Pei X; Zhu Y; Ng CKY; Curry M; Heller G; Zhang YK; Berger MF; Ladanyi M; Rudin CM; Chandarlapaty S; Lovly CM; Reis-Filho JS; Yu HA
Ann Oncol; 2022 Dec; 33(12):1284-1295. PubMed ID: 36089134
[TBL] [Abstract][Full Text] [Related]
17. Starfish infers signatures of complex genomic rearrangements across human cancers.
Bao L; Zhong X; Yang Y; Yang L
Nat Cancer; 2022 Oct; 3(10):1247-1259. PubMed ID: 35835961
[TBL] [Abstract][Full Text] [Related]
18. Molecular correlates of sensitivity to PARP inhibition beyond homologous recombination deficiency in pre-clinical models of colorectal cancer point to wild-type TP53 activity.
Smeby J; Kryeziu K; Berg KCG; Eilertsen IA; Eide PW; Johannessen B; Guren MG; Nesbakken A; Bruun J; Lothe RA; Sveen A
EBioMedicine; 2020 Sep; 59():102923. PubMed ID: 32799124
[TBL] [Abstract][Full Text] [Related]
19. The mutational landscapes of genetic and chemical models of Kras-driven lung cancer.
Westcott PM; Halliwill KD; To MD; Rashid M; Rust AG; Keane TM; Delrosario R; Jen KY; Gurley KE; Kemp CJ; Fredlund E; Quigley DA; Adams DJ; Balmain A
Nature; 2015 Jan; 517(7535):489-92. PubMed ID: 25363767
[TBL] [Abstract][Full Text] [Related]
20. Defining Signatures of Arm-Wise Copy Number Change and Their Associated Drivers in Kidney Cancers.
Benstead-Hume G; Wooller SK; Downs JA; Pearl FMG
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31744086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
